Acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution — RxCUI 993755
RxNorm drug concept · Semantic clinical drug
RxCUI 993755
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI993755
Official nameAcetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 24 MG/ML / Codeine Phosphate 2.4 MG/ML Oral Solution; codeine phosphate 12 MG / acetaminophen 120 MG in 5 mL Oral Solution; acetaminophen 120 MG / codeine phosphate 12 MG per 5 ML Oral Solution; acetaminophen 300 MG / codeine phosphate 30 MG per 12.5 ML Oral Solution
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)2,333 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetaminophen and Codeine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This combination is used to treat mild to moderate pain — things like post-surgical pain or musculoskeletal injuries — when other options like ibuprofen or acetaminophen alone have...
- What exactly is this medication for, and is it really necessary for me to take an opioid?
- The oral solution needs to be measured very carefully, because errors between milligrams and milliliters — or mixing it up with a different strength — can be dangerous. Always use...
- How should I take the liquid version without making a dosing mistake?
🕸️ Concept Web — How Acetaminophen 24 MG/ML / codeine phosphate 2.4 M... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution
RxCUI 993755 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Codeine
2670IN -
Acetaminophen / codeine
817579MIN -
Codeine phosphate
2672PIN
-
Acetaminophen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / codeine Oral Solution
370751SCDF -
Acetaminophen / codeine phosphate Oral Solution
2648519SCDFP -
Acetaminophen / codeine Oral Liquid Product
1155597SCDG -
Acetaminophen / codeine Oral Product
1155598SCDG -
Acetaminophen / codeine phosphate Oral Liquid Product
2662988SCDGP -
Acetaminophen / codeine phosphate Oral Product
2662072SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Acetaminophen / codeine Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 24 MG/ML
315256SCDC -
Codeine phosphate 2.4 MG/ML
993754SCDC
-
Acetaminophen 24 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetaminophen 24 MG/ML
SCDC · 315256 -
Codeine phosphate 2.4 MG/ML
SCDC · 993754 -
Acetaminophen / codeine Oral Solution
SCDF · 370751 -
Acetaminophen / codeine phosphate Oral Solution
SCDFP · 2648519 -
Acetaminophen / codeine Oral Liquid Product
SCDG · 1155597 -
Acetaminophen / codeine Oral Product
SCDG · 1155598 -
Acetaminophen / codeine phosphate Oral Liquid Product
SCDGP · 2662988 -
Acetaminophen / codeine phosphate Oral Product
SCDGP · 2662072
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 993755 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00121-1008-12 | 12.5 mL in 1 CUP, UNIT-DOSE (0121-1008-12) | Acetaminophen and Codeine Phosphate | PAI Holdings, LLC dba PAI Pharma | 2024-10-07 |
| 00121-1008-40 | 40 TRAY in 1 CASE (0121-1008-40) / 10 CUP, UNIT-DOSE in 1 T... | Acetaminophen and Codeine Phosphate | PAI Holdings, LLC dba PAI Pharma | 1981-08-21 |
| 64950-0374-04 | 118 mL in 1 BOTTLE, PLASTIC (64950-374-04) | Acetaminophen and Codeine Phosphate | Genus Lifesciences Inc. | 2023-08-10 |
| 64950-0374-16 | 473 mL in 1 BOTTLE, PLASTIC (64950-374-16) | Acetaminophen and Codeine Phosphate | Genus Lifesciences Inc. | 2023-08-10 |
Observed labelers:
Genus Lifesciences Inc. (2) ·
PAI Holdings, LLC dba PAI Pharma (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.